CSL signs agreement to deliver Covid vaccine
Biotechnology giant CSL has signed a final agreement with the federal government to supply 51 million doses of a University of Queensland-CSL vaccine should the drug be proven effective and safe in clinical trials. CSL’s vaccine subsidiary, Seqirus signed the agreement covering the vaccine candidate V451 and will receive an upfront payment from Canberra. The…